ZC3HC1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.62436730732907E-12 |
Normal-vs-Stage2 |
1.162190E-03 |
Normal-vs-Stage3 |
9.76549996423159E-09 |
Normal-vs-Stage4 |
1.502900E-03 |
Stage1-vs-Stage2 |
1.872830E-01 |
Stage1-vs-Stage3 |
8.764800E-01 |
Stage1-vs-Stage4 |
1.198850E-01 |
Stage2-vs-Stage3 |
1.820620E-01 |
Stage2-vs-Stage4 |
8.925000E-01 |
Stage3-vs-Stage4 |
1.157360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62436730732907E-12 |
Normal-vs-AfricanAmerican |
2.96019997403363E-09 |
Normal-vs-Asian |
5.625500E-02 |
Caucasian-vs-AfricanAmerican |
6.570200E-01 |
Caucasian-vs-Asian |
8.419600E-01 |
AfricanAmerican-vs-Asian |
9.950000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
6.23790019638193E-10 |
Male-vs-Female |
8.432000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
6.12560000501361E-08 |
Normal-vs-Extreme_Weight |
<1E-12 |
Normal-vs-Obese |
1.38470013233416E-10 |
Normal-vs-Extreme_Obese |
1.318680E-03 |
Normal_Weight-vs-Extreme_Weight |
4.683000E-01 |
Normal_Weight-vs-Obese |
7.586600E-01 |
Normal_Weight-vs-Extreme_Obese |
6.913000E-01 |
Extreme_Weight-vs-Obese |
6.492800E-01 |
Extreme_Weight-vs-Extreme_Obese |
9.648200E-01 |
Obese-vs-Extreme_Obese |
8.139600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.54049999995443E-06 |
Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(61-80Yrs) |
<1E-12 |
Normal-vs-Age(81-100Yrs) |
1.763370E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.665000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.969400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.207400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.365590E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.795200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.493200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
<1E-12 |
Normal-VS-Type2 PRCC |
4.78383999080734E-12 |
Normal-VS-KIRP CIMP |
2.203900E-02 |
Normal-VS-Unclassified PRCC |
6.58790000329645E-08 |
Type1 PRCC-VS-Type2 PRCC |
4.431200E-04 |
Type1 PRCC-VS-KIRP CIMP |
4.765800E-02 |
Type1 PRCC-VS-Unclassified PRCC |
2.178300E-04 |
Type2 PRCC-VS-KIRP CIMP |
5.732800E-01 |
Type2 PRCC-VS-Unclassified PRCC |
7.285200E-01 |
KIRP CIMP-VS-Unclassified PRCC |
6.907000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.13751238931081E-12 |
Normal-vs-N1 |
6.78659999975295E-07 |
Normal-vs-N2 |
2.793800E-01 |
N0-vs-N1 |
5.998800E-01 |
N0-vs-N2 |
4.194400E-01 |
N1-vs-N2 |
3.720000E-01 |
|
|